Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Pediatrics

Does a Baby's Positive SPCD Screen Mean the Mother Has It?

At a Glance

Yes, a baby's positive newborn screen for low carnitine (SPCD) often means the mother has the condition. Babies rely on their mother's carnitine during pregnancy, so low maternal levels cause temporarily low infant levels. The mother requires testing, and the baby may be perfectly healthy.

Yes, it is entirely possible—and in fact, it is a very common way for mothers to be diagnosed with Systemic Primary Carnitine Deficiency (SPCD). You may also see this condition called Primary Carnitine Deficiency (PCD) or Carnitine Uptake Defect (CUD).

When a newborn screening comes back positive for low free carnitine (often listed as C0 on the test results), it does not automatically mean the baby has SPCD [1][2]. Because a baby gets their carnitine from their mother during pregnancy, the baby’s carnitine levels right after birth are a direct reflection of the mother’s levels [1][2]. If the mother has undiagnosed SPCD, her carnitine levels will be low, meaning she could not pass enough carnitine to her baby through the placenta [1][3].

As a result, the baby will flag positive on the newborn screen because of this temporary low supply, even if the baby does not actually have the disease [1].

The Placenta Connection

Carnitine is an essential nutrient that helps the body turn fat into energy. During pregnancy, the baby relies completely on the mother for their supply of carnitine. The placenta acts as a bridge, actively transporting carnitine from the mother’s blood into the baby’s blood [3][4].

If a mother has SPCD, her body has trouble holding onto carnitine, causing her blood levels to drop significantly [2]. Because she does not have enough carnitine circulating in her own blood, the placenta cannot transfer an adequate amount to the baby [1][2].

Is the Baby Healthy?

In many of these cases, the baby is perfectly healthy. It is very common for the baby to be just a “carrier” of the SPCD gene mutation (the SLC22A5 gene) [1]. Being a carrier means the baby inherited one mutated gene from the mother, but assuming they inherited a normal gene from the father, they have enough functional genes to process carnitine normally [1]. Once the baby starts eating and producing their own carnitine, their levels will typically rise to normal.

However, because the baby’s levels were low at birth, the newborn screen will still trigger a “positive” or “abnormal” result, often referred to as a false-positive for the infant [1][5]. This result mandates that doctors test the mother’s blood to see if maternal SPCD is the true cause, and also necessitates re-testing the baby to confirm whether they actually have the condition or are just a carrier [1][6].

Why Was the Mother Never Diagnosed?

It is completely normal to wonder how you could have a genetic metabolic condition and never know it. Many adults with SPCD are completely asymptomatic, meaning they show absolutely no signs of the disease [7][8].

However, pregnancy places immense physical and metabolic stress on the body. A maternal diagnosis of SPCD triggered by a baby’s newborn screen is actually a lifesaving discovery in disguise [1]. If left completely untreated, adults with SPCD are at a higher risk for sudden heart issues (like cardiomyopathy, a weakening of the heart muscle) or dangerous drops in energy during illness or fasting [7][9].

What to Do While You Wait for Results

While you are waiting for follow-up blood and genetic tests, there are a few important steps you can take to protect yourself and your baby:

  • Avoid Fasting: The major danger with SPCD is that the body struggles to use fat for energy when it runs out of food. It is vital to avoid skipping meals. As a new mother, it is incredibly easy to forget to eat due to exhaustion, but you must eat regular meals and stay hydrated to prevent dangerous energy drops [10][11].
  • Discuss Feeding Plans: You will need to discuss infant feeding with your pediatrician right away. You should specifically ask if your breastmilk alone is sufficient for now, or if your baby needs an L-carnitine supplement or formula while you wait for both of your test results.
  • Monitor Your Energy: It is notoriously difficult to tell the difference between “normal postpartum exhaustion” and fatigue caused by SPCD. If you feel extreme weakness, confusion, or heart palpitations, contact your medical team immediately.

Next Steps for the Family

When a baby’s newborn screen suggests the mother might have SPCD, doctors will quickly recommend a few follow-up steps:

  • Maternal Blood Test: The mother’s blood will be drawn to check her free carnitine (C0) and total carnitine levels. If they are very low, it strongly points to maternal SPCD [1][12].
  • Genetic Testing: Both the mother and the baby may undergo genetic testing to look for mutations in the SLC22A5 gene, which confirms the diagnosis and determines if the baby is a carrier or affected [1][6].
  • L-carnitine Supplementation: If the mother is diagnosed, she will likely be prescribed lifelong L-carnitine supplements. This simple, highly effective treatment prevents severe complications for the mother and makes future pregnancies safer [9][13].

Common questions in this guide

What does a positive newborn screen for SPCD mean for the mother?
A positive newborn screen for low carnitine often means the mother has undiagnosed Systemic Primary Carnitine Deficiency (SPCD). Because babies rely on their mother's carnitine supply during pregnancy, the baby's low levels at birth may simply reflect the mother's deficiency.
Is my baby healthy if they had a positive SPCD newborn screen?
In many cases where the screen points to the mother, the baby is perfectly healthy and may just be a carrier of the SPCD gene mutation. Once the baby starts producing and consuming their own carnitine, their levels typically return to normal.
How could I have SPCD and never know it before pregnancy?
Many adults with SPCD are completely asymptomatic, meaning they show no signs of the disease under normal conditions. Pregnancy places immense metabolic stress on the body, which is why the condition is often discovered for the first time through a baby's newborn screening.
What should I do while waiting for follow-up SPCD test results?
It is critical to avoid fasting and skipping meals while waiting for results, as your body may struggle to use fat for energy. You should also discuss feeding plans with your pediatrician to determine if your baby needs an L-carnitine supplement or formula in the meantime.
How is maternal SPCD treated?
If a mother is diagnosed with SPCD, she is typically prescribed lifelong L-carnitine supplements. This simple and highly effective treatment prevents severe complications like heart issues and makes future pregnancies safer.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What were the exact free carnitine (C0) levels on my baby's newborn screen, and when will my baby's levels be re-tested?
  2. 2.Is it safe and sufficient to breastfeed my baby right now, or should we use formula or supplements until our test results are finalized?
  3. 3.When and how will my own serum carnitine levels be tested?
  4. 4.Should we proceed with genetic testing for the SLC22A5 gene for both myself, the baby, and my partner?
  5. 5.If I am diagnosed with SPCD, what is the recommended dose of L-carnitine I should start taking, and how quickly should I start?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    A newborn with seizures born to a mother diagnosed with primary carnitine deficiency.

    Chen S, Hu Y, Huang Y, et al.

    BMC pediatrics 2019; (19(1)):79 doi:10.1186/s12887-019-1452-4.

    PMID: 30885166
  2. 2

    Molecular investigation in Chinese patients with primary carnitine deficiency.

    Zhang Y, Li H, Liu J, et al.

    Molecular genetics & genomic medicine 2019; (7(9)):e901 doi:10.1002/mgg3.901.

    PMID: 31364285
  3. 3

    Embryonic lethality in mice due to carnitine transporter OCTN2 defect and placental carnitine deficiency.

    Shekhawat PS, Sonne S, Matern D, Ganapathy V

    Placenta 2018; (69()):71-73 doi:10.1016/j.placenta.2018.06.312.

    PMID: 30213487
  4. 4

    L-carnitine increases cell proliferation and amino acid transporter expression via the activation of insulin-like growth factor I signaling pathway in rat trophoblast cells.

    Zhang S, Wu Z, Heng J, et al.

    Food science & nutrition 2020; (8(7)):3298-3307 doi:10.1002/fsn3.1607.

    PMID: 32724594
  5. 5

    Benefits and pitfalls in newborn screening for carnitine uptake deficiency: a 4-year single-center experience.

    Turturo M, Rossi A, Barretta F, et al.

    Orphanet journal of rare diseases 2025; (21(1)).

    PMID: 41310792
  6. 6

    Functional and molecular studies in primary carnitine deficiency.

    Frigeni M, Balakrishnan B, Yin X, et al.

    Human mutation 2017; (38(12)):1684-1699 doi:10.1002/humu.23315.

    PMID: 28841266
  7. 7

    A qualitative study on the perspectives of mothers who had been diagnosed with primary carnitine deficiency through newborn screening of their child.

    van den Heuvel LM, Kater-Kuipers A, van Dijk T, et al.

    Orphanet journal of rare diseases 2023; (18(1)):134 doi:10.1186/s13023-023-02735-0.

    PMID: 37268964
  8. 8

    Molecular Autopsy Implicates Primary Carnitine Deficiency in Sudden Unexplained Death and Reversible Short QT Syndrome.

    Gélinas R, Leach E, Horvath G, Laksman Z

    The Canadian journal of cardiology 2019; (35(9)):1256.e1-1256.e2 doi:10.1016/j.cjca.2019.05.014.

    PMID: 31472821
  9. 9

    Primary carnitine deficiency - diagnosis after heart transplantation: better late than never!

    Grünert SC, Tucci S, Schumann A, et al.

    Orphanet journal of rare diseases 2020; (15(1)):87 doi:10.1186/s13023-020-01371-2.

    PMID: 32276632
  10. 10

    A Rare Case Report of Hypoketotic Hypoglycemia Induced Seizures Due to Secondary Carnitine Deficiency in a 44-year-old Female.

    Bangolo A, Tesoro N, Onyeka S, et al.

    Journal of community hospital internal medicine perspectives 2024; (14(3)):68-71 doi:10.55729/2000-9666.1279.

    PMID: 39036584
  11. 11

    Systemic primary carnitine deficiency with hypoglycemic encephalopathy.

    Jun JS, Lee EJ, Park HD, Kim HS

    Annals of pediatric endocrinology & metabolism 2016; (21(4)):226-229 doi:10.6065/apem.2016.21.4.226.

    PMID: 28164076
  12. 12

    Carnitine uptake defect due to a 5'UTR mutation in a pedigree with false positives and false negatives on Newborn screening.

    Verbeeten KC, Lamhonwah AM, Bulman D, et al.

    Molecular genetics and metabolism 2020; (129(3)):213-218 doi:10.1016/j.ymgme.2019.12.006.

    PMID: 31864849
  13. 13

    Primary Carnitine Deficiency: A Rare, Reversible Metabolic Cardiomyopathy.

    Tomlinson S, Atherton J, Prasad S

    Case reports in cardiology 2018; (2018()):3232105 doi:10.1155/2018/3232105.

    PMID: 30302293

This page explains newborn screening results for SPCD for educational purposes. Your pediatrician and metabolic specialist are the best sources for interpreting your specific test results and creating a care plan.

Get notified when new evidence is published on Systemic primary carnitine deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.